Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00086138 · ClinicalTrials.gov registry record · Phase 2
Depression in Alzheimer's Disease-2
A Phase 2 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
NCT00086138: Completed Phase 2 study, sponsored by Johns Hopkins University.
NCT00086138 is a Phase 2 study that has completed, run by Johns Hopkins University. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00086138, a Phase 2 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.
Interventions
- DRUG Placebo
- DRUG Sertraline (Zoloft)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2004-07 |
| Est. Completion | 2009-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00086138
The ClinicalTrials.gov registry entry for NCT00086138 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00086138 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00086138 about?
NCT00086138 is a clinical study titled "Depression in Alzheimer's Disease-2". The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.
What is the current status of trial NCT00086138?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2004-07. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00086138?
The interventions under investigation include: Placebo (DRUG), Sertraline (Zoloft) (DRUG).
Who is sponsoring clinical trial NCT00086138?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.